| Patents for A61P 27 - Drugs for disorders of the senses (53,017) |
|---|
| 05/26/2006 | WO2006053629A1 Retina-specific cells differentiated in vitro from bone marrow stem cells, the production thereof and their use |
| 05/26/2006 | WO2006031786A3 Protein a compositions and methods of use |
| 05/26/2006 | WO2006006079A3 Methods for suppressing neovascularization using ephrinb2 |
| 05/26/2006 | WO2005110438A3 Methods and products related to the intracellular delivery of polysaccharides |
| 05/26/2006 | CA2588056A1 2,3,4-substituted cyclopentanones as therapeutic agents |
| 05/26/2006 | CA2587391A1 Compositions useful to treat ocular neovascular diseases and macular degeneration |
| 05/25/2006 | US20060111567 Nonpeptide substituted spirobenzoazepines as vasopressin antagonists |
| 05/25/2006 | US20060111419 Novel fused indazole compounds |
| 05/25/2006 | US20060111397 Methods and compositions for treating diseases associated with excesses in ACE |
| 05/25/2006 | US20060111375 Compound having tgfß inhibitory activity and medicinal composition containing the same |
| 05/25/2006 | US20060111340 1-thia-3-aza-dibenzoazulenes as inhibitors of tumour necrosis factor production and intermediates for the preparation thereof |
| 05/25/2006 | US20060111286 Method of modulating endothelial cell activity |
| 05/25/2006 | US20060111278 TFF peptides |
| 05/25/2006 | US20060110474 Rubrofusarin glycoside-containing composition |
| 05/25/2006 | US20060110356 Ophthalmic drug delivery system using polymer micelle |
| 05/24/2006 | EP1659120A1 3-substituted quinoline-4-carboxamide derivatives as NK-3 and NK-2 receptor antagonists |
| 05/24/2006 | EP1658849A2 Therapeutic combinations of antihypertensive and antiangiogenic agents |
| 05/24/2006 | EP1658263A1 Novel aminobenzophenone compounds |
| 05/24/2006 | EP1506185B1 Compounds and their use as inhibitors of 5-ht |
| 05/24/2006 | EP1384477B1 Utilization of pyrazoline derivatives in the preparation of a medicament for the prevention and/or treatment of proliferative cell diseases |
| 05/24/2006 | EP1333841B1 M. tuberculosis chaperonin 10 and uses thereof |
| 05/24/2006 | EP0979652B1 Remedial composition for intraocular hypertension or glaucoma |
| 05/24/2006 | CN1777608A Fused pyrimidine derivative |
| 05/24/2006 | CN1777595A Derivatives of dioxane-2-alkyl carbamates, preparation thereof and application thereof in therapeutics |
| 05/24/2006 | CN1777580A Prostaglandin derivatives |
| 05/24/2006 | CN1777445A Agent for repairing corneal perception |
| 05/24/2006 | CN1775801A Low molecular weight peptide derivatives as inhibitors of the laminin/nidogen interaction |
| 05/24/2006 | CN1775283A Reduced glutathione eye medicinal preparation |
| 05/24/2006 | CN1775263A Qiju-dihuang preparation and new preparation method |
| 05/24/2006 | CN1775261A Mingmu-Dihuang preparation and new preparing method |
| 05/24/2006 | CN1775259A Anemarrhena preparation and new preparation method |
| 05/24/2006 | CN1775254A Medicinal preparation for treating deaf and preparing method |
| 05/24/2006 | CN1775232A Preparation for treating trachoma |
| 05/24/2006 | CN1775225A Thyroxine liothyronine eyedrops |
| 05/24/2006 | CN1775210A Ftibamzone eyedrops |
| 05/24/2006 | CN1775206A Phacolysin eye medicinal formulation |
| 05/24/2006 | CN1257160C Aimoquinoline and aminopyridine derivatives and their use as adenosine A3 ligands |
| 05/23/2006 | US7049439 Immunomodulators for inducing cytokine biosynthesis; viricides; antitumor agents |
| 05/23/2006 | US7049340 administering ramipril, ramiprilat or other ramiprilat derivative; for improving visual acuity and visual field in normal subjects, as well as for treating ophthalmologic pathologies involving vascular factor, in particular glaucomatous neuropathy, degenerative choriopathy of strong myopia |
| 05/23/2006 | US7049331 1,2,4-thiadiazole derivatives as melanocortin receptor modulators |
| 05/23/2006 | US7049329 Phenylalkylene-substituted or allyloxyphenylmethyl-substituted, e.g., N-(p-allyloxybenzyl-N-(2-methoxyethyl)-N-(3-phenylallyl)amine; endocannabinoid agonists |
| 05/23/2006 | US7049322 Compositions and formulations of 9-nitrocamptothecin polymorphs and methods of use therefor |
| 05/23/2006 | US7049321 Methods and pharmaceutical compositions for treatment of central and peripheral nervous system disorders and compounds useful therefor |
| 05/23/2006 | US7049320 Drugs for treating physiological disorder, respiratory disorders, inflammatory disease, skin disorder, and antidepressants, treating bipolar disorder, drug abuse, drug dependence, gastrointestinal disorder, atherosclerosis |
| 05/23/2006 | US7049312 2H-1,4-benzothiazin-3(4H)-one derivative as anticarcinogenic and antiproliferative agent; inhibitors of serine/threonine and tyrosine kinase activity |
| 05/23/2006 | US7049306 Heteroaryl, heterocyclic and aryl compounds which inhibit leukocyte adhesion mediated by VLA-4. |
| 05/23/2006 | US7048933 Mixing shoots of Pinaceae plants with water and saccharides followed by spontaneous fermenting with yeasts to form remedies for allergic diseases; side effect reduction; for treatment of asthma, atopic dermatitis |
| 05/23/2006 | US7048906 Methods of diagnosing and treating small intestinal bacterial overgrowth (SIBO) and SIBO-related conditions |
| 05/23/2006 | CA2339630C Carboline derivatives as cgmp phosphodiesterase inhibitors |
| 05/18/2006 | WO2006052950A1 5,6,7-trihydroxyheptanoic acid and analogs for the treatment of ocular diseases and diseases associated with hyperproliferative and angiogenic responses |
| 05/18/2006 | WO2006052630A1 Therapeutic substituted piperidone compounds |
| 05/18/2006 | WO2006052018A1 Aqueous ophthalmic suspension of crystalline rebamipide |
| 05/18/2006 | WO2006051826A1 Nitrogenous heterocyclic compound and pharmaceutical use thereof |
| 05/18/2006 | WO2006051137A1 Method of obtaining derivatives of 4-(n-alkylamine)-5,6-dihydro-4h-thieno-[2,3-b]-thiopyran |
| 05/18/2006 | WO2006020979A3 Factor vii conjugates for selectively treating neovascularization disorders |
| 05/18/2006 | WO2006007227A3 Abnormal cannabidiols for lowering intraocular pressure |
| 05/18/2006 | WO2004041134A8 Eyelid margin wipes comprising chemical means for temperature adjustment |
| 05/18/2006 | US20060106222 Aminoadamantane derivatives as therapeutic agents |
| 05/18/2006 | US20060106220 Compositions and therapeutic methods involving isoflavones and analogues thereof |
| 05/18/2006 | US20060106082 N-[4-[5-(4-methylphenyl)-3-(trifluoromethyl)-1H-pyrazol-1-yl]phenylsulfonyl]-4-nitrooxybutanamide, used for the treatment of inflammatory, cardiovascular, gastrointestinal, respiratory and nervous system disorders, as analgesics, antipyretics and antocoagulants or for organ and tissue preservation |
| 05/18/2006 | US20060106078 Prostamide receptor antagonists |
| 05/18/2006 | US20060106075 Benzothiazole derivatives having beta-2-adrenoreceptor agonist activity |
| 05/18/2006 | US20060106074 Er-b-selective ligands |
| 05/18/2006 | US20060106056 Novel quinuclidine derivatives and medicinal compositions containing the same |
| 05/18/2006 | US20060106055 Novel quinuclidine derivatives and medicinal compositions containing the same |
| 05/18/2006 | US20060106046 2-(3,4-difluorophenyl)-N-methyl-2-(1H-1,2,3-triazol-1-yl)-N-[3-(spiro[isobenzofuran-1(3H), 4'-piperidin]-1-yl)propyl]acetamide, used for preventing or treating cardiovascular, nervous, metabolic, reproductive, respiratory and/or digestive system disorders |
| 05/18/2006 | US20060106009 Use of caboxamides for the treatment of tinnitus |
| 05/18/2006 | US20060105957 Loop peptide and TGFalpha for stimulating stem cell proliferation and migration |
| 05/18/2006 | US20060105430 cleaving a heparin-like glycosaminoglycan using modified heparinases having altered binding specificity and activity; angiogenesis inhibition |
| 05/18/2006 | US20060104963 Use of transfected stem cell population expressing an antiangiogenic fragment of human tryptophanyl tRNA synthetase (TrpRS); cell-based gene therapy |
| 05/18/2006 | US20060103807 Ophthalmic and ophthalmological use of a complex nutritive base in an aqueous medium |
| 05/18/2006 | DE102004055615A1 In vitro aus Knochenmarkstammzellen differenzierte Retina-spezifische Zellen, ihre Herstellung und Verwendung In vitro from bone marrow stem cells differentiated retina-specific cells, their preparation and use |
| 05/18/2006 | CA2586752A1 Substituted pyrrolidone compounds as ep4 agonists |
| 05/18/2006 | CA2584286A1 5,6,7-trihydroxyheptanoic acid and analogs for the treatment of ocular diseases and diseases associated with hyperproliferative and angiogenic responses |
| 05/18/2006 | CA2584017A1 Aqueous ophthalmic suspension of crystalline rebamipide |
| 05/18/2006 | CA2578176A1 Ophthalmic emulsions containing an immunosuppressive agent |
| 05/17/2006 | EP1657954A1 Transmitter of wireless microphone, receiver for wireless microphone, mobile information communication apparatus, and communication system for wireless microphone |
| 05/17/2006 | EP1657233A1 Lipoxin compounds |
| 05/17/2006 | EP1656123A2 Anti-candida agents for the treatment of prion diseases |
| 05/17/2006 | EP1543003B1 Imidazo¬1,2-a|pyridines |
| 05/17/2006 | CN1774251A Method of treating ophthalmic disorders with epoxy-steroidal aldosterone receptor antagonists |
| 05/17/2006 | CN1774245A Preventive/remedy for retinal nerve diseases containing alkyl ether derivatives or salts thereof |
| 05/17/2006 | CN1772261A Oral medicine for treafing eye inflammation, lession and hemorrhage and its prepn |
| 05/17/2006 | CN1772249A Chinese herbal medicine decoction for treating spleen deficiency wetness type senile cataract and its prepn |
| 05/17/2006 | CN1772185A Chinese herbal medicine decoction for treating senile cataract caused by wind-heat evil attacking liver channel and its prepn |
| 05/17/2006 | CN1772177A Orally taken medicine for treating climacteric xerophthalmia and its prepn |
| 05/17/2006 | CN1772167A Chinese herbal medicine decoction for treating liver and kidney Yin deficiency type senile cataract and its prepn |
| 05/17/2006 | CN1772166A Chinese herbal medicine decoction for treating kidney-Yang deficiency type senile cataract and its prepn |
| 05/17/2006 | CN1771998A Eye medicine prepn of effective shellfish component and its use |
| 05/17/2006 | CN1771919A Compound soft lutein capsule and its prepn process |
| 05/17/2006 | CN1771840A Nutrient food capable of preventing cataract and muscae volitantes and its making process |
| 05/17/2006 | CN1256326C 4-(oxyalkoxyphenyl)-3-oxy-piperidines for treating heart and kidney insufficiency |
| 05/17/2006 | CN1256151C Musk medicated thread and its preparation method |
| 05/17/2006 | CN1256128C Eye disease treating medicine |
| 05/17/2006 | CN1256111C Drink for treating xerophthalmia and alacrimia |
| 05/17/2006 | CN1256105C Oral liquid medicine from ferments of armilarilla tabescens |
| 05/17/2006 | CN1256094C 3'-Deoxyadenosine in application of preparing bypolipidemic |
| 05/16/2006 | US7045660 [di(ether or thioether)heteroaryl or fluoro substituted aryl] compound or an N-oxide thereof or a salt thereof, useful for inhibiting the production or physiological effects of TNF in treatment of a patient suffering from a disease state associated with a detrimental excess of tumor necrosis factor |
| 05/16/2006 | US7045658 prophylaxis and treatment of respiratory diseases; phenethanolamine derivatives |
| 05/16/2006 | US7045634 Prostamide receptor antagonists |